162 related articles for article (PubMed ID: 36877496)
21. Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders.
Leuzy A; Smith R; Ossenkoppele R; Santillo A; Borroni E; Klein G; Ohlsson T; Jögi J; Palmqvist S; Mattsson-Carlgren N; Strandberg O; Stomrud E; Hansson O
JAMA Neurol; 2020 Aug; 77(8):955-965. PubMed ID: 32391858
[TBL] [Abstract][Full Text] [Related]
22. Predicting neurological outcome after out-of-hospital cardiac arrest with cumulative information; development and internal validation of an artificial neural network algorithm.
Andersson P; Johnsson J; Björnsson O; Cronberg T; Hassager C; Zetterberg H; Stammet P; Undén J; Kjaergaard J; Friberg H; Blennow K; Lilja G; Wise MP; Dankiewicz J; Nielsen N; Frigyesi A
Crit Care; 2021 Feb; 25(1):83. PubMed ID: 33632280
[TBL] [Abstract][Full Text] [Related]
23. Association Between Plasma Biomarkers of Amyloid, Tau, and Neurodegeneration with Cerebral Microbleeds.
McCarter SJ; Lesnick TG; Lowe VJ; Rabinstein AA; Przybelski SA; Algeciras-Schimnich A; Ramanan VK; Jack CR; Petersen RC; Knopman DS; Boeve BF; Kantarci K; Vemuri P; Mielke MM; Graff-Radford J
J Alzheimers Dis; 2022; 87(4):1537-1547. PubMed ID: 35527558
[TBL] [Abstract][Full Text] [Related]
24. Association of Serum Brain-Derived Tau With Clinical Outcome and Longitudinal Change in Patients With Severe Traumatic Brain Injury.
Gonzalez-Ortiz F; Dulewicz M; Ashton NJ; Kac PR; Zetterberg H; Andersson E; Yakoub Y; Hanrieder J; Turton M; Harrison P; Nellgård B; Karikari TK; Blennow K
JAMA Netw Open; 2023 Jul; 6(7):e2321554. PubMed ID: 37399012
[TBL] [Abstract][Full Text] [Related]
25. Clinical usefulness of cerebrospinal fluid biomarkers in Alzheimer's disease.
Peña-Bautista C; Álvarez-Sánchez L; Pascual R; Moreno MJ; Baquero M; Cháfer-Pericás C
Eur J Clin Invest; 2023 Mar; 53(3):e13910. PubMed ID: 36401799
[TBL] [Abstract][Full Text] [Related]
26. Plasma p-tau231, p-tau181, PET Biomarkers, and Cognitive Change in Older Adults.
Meyer PF; Ashton NJ; Karikari TK; Strikwerda-Brown C; Köbe T; Gonneaud J; Pichet Binette A; Ozlen H; Yakoub Y; Simrén J; Pannee J; Lantero-Rodriguez J; Labonté A; Baker SL; Schöll M; Vanmechelen E; Breitner JCS; Zetterberg H; Blennow K; Poirier J; Villeneuve S;
Ann Neurol; 2022 Apr; 91(4):548-560. PubMed ID: 35084051
[TBL] [Abstract][Full Text] [Related]
27. Concordance Between Different Amyloid Immunoassays and Visual Amyloid Positron Emission Tomographic Assessment.
Janelidze S; Pannee J; Mikulskis A; Chiao P; Zetterberg H; Blennow K; Hansson O
JAMA Neurol; 2017 Dec; 74(12):1492-1501. PubMed ID: 29114726
[TBL] [Abstract][Full Text] [Related]
28. Serum markers of brain injury can predict good neurological outcome after out-of-hospital cardiac arrest.
Moseby-Knappe M; Mattsson-Carlgren N; Stammet P; Backman S; Blennow K; Dankiewicz J; Friberg H; Hassager C; Horn J; Kjaergaard J; Lilja G; Rylander C; Ullén S; Undén J; Westhall E; Wise MP; Zetterberg H; Nielsen N; Cronberg T
Intensive Care Med; 2021 Sep; 47(9):984-994. PubMed ID: 34417831
[TBL] [Abstract][Full Text] [Related]
29. Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease.
Leuzy A; Smith R; Cullen NC; Strandberg O; Vogel JW; Binette AP; Borroni E; Janelidze S; Ohlsson T; Jögi J; Ossenkoppele R; Palmqvist S; Mattsson-Carlgren N; Klein G; Stomrud E; Hansson O
JAMA Neurol; 2022 Feb; 79(2):149-158. PubMed ID: 34928318
[TBL] [Abstract][Full Text] [Related]
30. Neurofilament light chain in the vitreous humor of the eye.
Subramanian ML; Vig V; Chung J; Fiorello MG; Xia W; Zetterberg H; Blennow K; Zetterberg M; Shareef F; Siegel NH; Ness S; Jun GR; Stein TD
Alzheimers Res Ther; 2020 Sep; 12(1):111. PubMed ID: 32943089
[TBL] [Abstract][Full Text] [Related]
31. Dynamics of plasma biomarkers in Down syndrome: the relative levels of Aβ42 decrease with age, whereas NT1 tau and NfL increase.
Mengel D; Liu W; Glynn RJ; Selkoe DJ; Strydom A; Lai F; Rosas HD; Torres A; Patsiogiannis V; Skotko B; Walsh DM
Alzheimers Res Ther; 2020 Mar; 12(1):27. PubMed ID: 32192521
[TBL] [Abstract][Full Text] [Related]
32. Development of a Plasma Biomarker Diagnostic Model Incorporating Ultrasensitive Digital Immunoassay as a Screening Strategy for Alzheimer Disease in a Chinese Population.
Wu X; Xiao Z; Yi J; Ding S; Gu H; Wu W; Luo J; Liang X; Zheng L; Xu H; Zhao Q; Ding D
Clin Chem; 2021 Nov; 67(12):1628-1639. PubMed ID: 34662373
[TBL] [Abstract][Full Text] [Related]
33. CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.
Mattsson N; Zetterberg H; Hansson O; Andreasen N; Parnetti L; Jonsson M; Herukka SK; van der Flier WM; Blankenstein MA; Ewers M; Rich K; Kaiser E; Verbeek M; Tsolaki M; Mulugeta E; Rosén E; Aarsland D; Visser PJ; Schröder J; Marcusson J; de Leon M; Hampel H; Scheltens P; Pirttilä T; Wallin A; Jönhagen ME; Minthon L; Winblad B; Blennow K
JAMA; 2009 Jul; 302(4):385-93. PubMed ID: 19622817
[TBL] [Abstract][Full Text] [Related]
34. Cerebrospinal Fluid Biomarkers in Cerebral Amyloid Angiopathy.
Banerjee G; Ambler G; Keshavan A; Paterson RW; Foiani MS; Toombs J; Heslegrave A; Dickson JC; Fraioli F; Groves AM; Lunn MP; Fox NC; Zetterberg H; Schott JM; Werring DJ
J Alzheimers Dis; 2020; 74(4):1189-1201. PubMed ID: 32176643
[TBL] [Abstract][Full Text] [Related]
35. Associations of longitudinal plasma p-tau181 and NfL with tau-PET, Aβ-PET and cognition.
Rauchmann BS; Schneider-Axmann T; Perneczky R;
J Neurol Neurosurg Psychiatry; 2021 Dec; 92(12):1289-1295. PubMed ID: 34187867
[TBL] [Abstract][Full Text] [Related]
36. Cerebrospinal fluid in the differential diagnosis of Alzheimer's disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic.
Paterson RW; Slattery CF; Poole T; Nicholas JM; Magdalinou NK; Toombs J; Chapman MD; Lunn MP; Heslegrave AJ; Foiani MS; Weston PSJ; Keshavan A; Rohrer JD; Rossor MN; Warren JD; Mummery CJ; Blennow K; Fox NC; Zetterberg H; Schott JM
Alzheimers Res Ther; 2018 Mar; 10(1):32. PubMed ID: 29558979
[TBL] [Abstract][Full Text] [Related]
37. Serum tau fragments as predictors of death or poor neurological outcome after out-of-hospital cardiac arrest.
Grand J; Kjaergaard J; Nielsen N; Friberg H; Cronberg T; Bro-Jeppesen J; Karsdal MA; Nielsen HB; Frydland M; Henriksen K; Mattsson N; Zetterberg H; Hassager C
Biomarkers; 2019 Sep; 24(6):584-591. PubMed ID: 31017476
[No Abstract] [Full Text] [Related]
38. Poor sleep is associated with CSF biomarkers of amyloid pathology in cognitively normal adults.
Sprecher KE; Koscik RL; Carlsson CM; Zetterberg H; Blennow K; Okonkwo OC; Sager MA; Asthana S; Johnson SC; Benca RM; Bendlin BB
Neurology; 2017 Aug; 89(5):445-453. PubMed ID: 28679595
[TBL] [Abstract][Full Text] [Related]
39. Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study.
de Wolf F; Ghanbari M; Licher S; McRae-McKee K; Gras L; Weverling GJ; Wermeling P; Sedaghat S; Ikram MK; Waziry R; Koudstaal W; Klap J; Kostense S; Hofman A; Anderson R; Goudsmit J; Ikram MA
Brain; 2020 Apr; 143(4):1220-1232. PubMed ID: 32206776
[TBL] [Abstract][Full Text] [Related]
40. Alzheimer's cerebrospinal biomarkers from Lumipulse fully automated immunoassay: concordance with amyloid-beta PET and manual immunoassay in Koreans : CSF AD biomarkers measured by Lumipulse in Koreans.
Moon S; Kim S; Mankhong S; Choi SH; Vandijck M; Kostanjevecki V; Jeong JH; Yoon SJ; Park KW; Kim EJ; Yoon B; Kim HJ; Jang JW; Hong JY; Park DH; Shaw LM; Kang JH
Alzheimers Res Ther; 2021 Jan; 13(1):22. PubMed ID: 33436035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
